The pathogenic role of the inflammasome in neurodegenerative diseases

Journal of Neurochemistry

Volumn 136, Issue , 2016, Pages 29-38

  Freeman, Leslie C ^a   Ting, Jenny P Y ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

IL 1 ; inflammasome; neurodegenerative diseases

Indexed keywords

AMYLOID BETA PROTEIN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; MEMBRANE PROTEIN; PROTEIN AIM2; PROTEIN NLRC4; PROTEIN NLRP1; UNCLASSIFIED DRUG; AUTACOID;

ALZHEIMER DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DISEASE MODEL; HUMAN; IMMUNOPRECIPITATION; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURY; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; BRAIN INJURIES; HUMANS; INFLAMMASOMES; INFLAMMATION; INFLAMMATION MEDIATORS; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION;

EID: 84956596401     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13217     Document Type: Review

References (72)

1. Adamczak S., Dale G., de Rivero Vaccari J. P., Bullock M. R., Dietrich W. D., and, Keane R. W., (2012) Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J. Neurosurg. 117, 1119-1125. doi: 10.3171/2012.9.JNS12815.
2. Adamczak S. E., de Rivero Vaccari J. P., Dale G., Brand F. J. 3rd, Nonner D., Bullock M. R., Dahl G. P., Dietrich W. D., and, Keane R. W., (2014) Pyroptotic neuronal cell death mediated by the AIM2 inflammasome. J. Cereb. Blood Flow Metab. 34, 621-629. doi: 10.1038/jcbfm.2013.236.
3. Balashov K. E., Rottman J. B., Weiner H. L., and, Hancock W. W., (1999) CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl Acad. Sci. USA 96, 6873-6878.
4. Bhat R., and, Steinman L., (2009) Innate and adaptive autoimmunity directed to the central nervous system. Neuron 64, 123-132. doi: 10.1016/j.neuron.2009.09.015.
5. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., and, Riederer P., (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202, 17-20.
6. Bossu P., Ciaramella A., Moro M. L., Bellincampi L., Bernardini S., Federici G., and, Spalletta G., (2007) Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 78, 807-811. doi: 10.1136/jnnp.2006.103242.
7. Cai X., Chen J., Xu H., Liu S., Jiang Q. X., Halfmann R., and, Chen Z. J., (2014) Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156, 1207-1222. doi: 10.1016/j.cell.2014.01.063.
8. Campello Yurgel V., Ikuta N., Brondani da Rocha A., Lunge V. R., Fett Schneider R., Kazantzi Fonseca A. S., and, Regner A., (2007). Role of plasma DNA as a predictive marker of fatal outcome following severe head injury in males. J. Neurotrauma 24, 1172-1181. doi: 10.1089/neu.2006.0160
9. Chaput C., Sander L. E., Suttorp N., and, Opitz B., (2013) NOD-Like Receptors in Lung Diseases. Front Immunol. 4, 393. doi: 10.3389/fimmu.2013.00393.
10. Chodobski A., Zink B. J., and, Szmydynger-Chodobska J., (2011) Blood-brain barrier pathophysiology in traumatic brain injury. Transl. Stroke Res. 2, 492-516. doi: 10.1007/s12975-011-0125-x.
11. Cirelli K. M., Gorfu G., Hassan M. A., Printz M., Crown D., Leppla S. H., and, Moayeri M., (2014) Inflammasome sensor NLRP1 controls rat macrophage susceptibility to Toxoplasma gondii. PLoS Pathog. 10, e1003927. doi: 10.1371/journal.ppat.1003927.
12. Coll R. C., Robertson A. A., Chae J. J., Higgins S. C., Munoz-Planillo R., Inserra M. C., and, O'Neill L. A., (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. doi: 10.1038/nm.3806.
13. Cristofori L., Tavazzi B., Gambin R., Vagnozzi R., Signoretti S., Amorini A. M., and, Lazzarino G., (2005) Biochemical analysis of the cerebrospinal fluid: evidence for catastrophic energy failure and oxidative damage preceding brain death in severe head injury: a case report. Clin. Biochem. 38, 97-100. doi: 10.1016/j.clinbiochem.2004.09.013.
14. Dasuri K., Zhang L., and, Keller J. N., (2013) Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 62, 170-185. doi: 10.1016/j.freeradbiomed.2012.09.016.
15. Davis B. K., Wen H., and, Ting J. P., (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707-735. doi: 10.1146/annurev-immunol-031210-101405.
16. Davis B. K., Philipson C., Hontecillas R., Eden K., Bassaganya-Riera J., and, Allen I. C., (2014) Emerging significance of NLRs in inflammatory bowel disease. Inflamm. Bowel Dis. 20, 2412-2432. doi: 10.1097/MIB.0000000000000151.
17. Denic A., Johnson A. J., Bieber A. J., Warrington A. E., Rodriguez M., and, Pirko I., (2011) The relevance of animal models in multiple sclerosis research. Pathophysiology 18, 21-29. doi: 10.1016/j.pathophys.2010.04.004.
18. Dostert C., and, Petrilli V., (2008) Asbestos triggers inflammation by activating the Nalp3 inflammasome. Med. Sci. (Paris) 24, 916-918. doi: 10.1051/medsci/20082411916.
19. Duncan J. A., Bergstralh D. T., Wang Y., Willingham S. B., Ye Z., Zimmermann A. G., and, Ting J. P., (2007) Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc. Natl Acad. Sci. USA 104, 8041-8046. doi: 10.1073/pnas.0611496104.
20. Faustin B., and, Reed J. C., (2013) Reconstituting the NLRP1 inflammasome in vitro. Methods Mol. Biol. 1040, 137-152. doi: 10.1007/978-1-62703-523-1-11.
21. Feder L. S., and, Laskin D. L., (1994) Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia. J. Leukoc. Biol. 55, 507-513.
22. Fernandes-Alnemri T., Yu J. W., Datta P., Wu J., and, Alnemri E. S., (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509-513. doi: 10.1038/nature07710.
23. Franchi L., Amer A., Body-Malapel M., Kanneganti T. D., Ozoren N., Jagirdar R., and, Nunez G., (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7, 576-582. doi: 10.1038/ni1346.
24. Furlan R., Martino G., Galbiati F., Poliani P. L., Smiroldo S., Bergami A., and, Adorini L., (1999) Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J. Immunol. 163, 2403-2409.
25. Geekiyanage H., and, Chan C., (2011) MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J. Neurosci. 31, 14820-14830. doi: 10.1523/JNEUROSCI.3883-11.2011.
26. Geekiyanage H., Upadhye A., and, Chan C., (2013) Inhibition of serine palmitoyltransferase reduces Abeta and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease. Neurobiol. Aging 34, 2037-2051. doi: 10.1016/j.neurobiolaging.2013.02.001.
27. Ghosh S., Wu M. D., Shaftel S. S., Kyrkanides S., LaFerla F. M., Olschowka J. A., and, O'Banion M. K., (2013) Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model. J. Neurosci. 33, 5053-5064. doi: 10.1523/JNEUROSCI.4361-12.2013.
28. Griffin W. S., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., and, Araoz C., (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 7611-7615.
29. Gris D., Ye Z., Iocca H. A., Wen H., Craven R. R., Gris P., and, Ting J. P., (2010) NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 185, 974-981. doi: 10.4049/jimmunol.0904145.
30. Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Forster I., and, Tschopp J., (2011) Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34, 213-223. doi: 10.1016/j.immuni.2011.02.006.
31. Halle A., Hornung V., Petzold G. C., Stewart C. R., Monks B. G., Reinheckel T., and, Golenbock D. T., (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857-865. doi: 10.1038/ni.1636.
32. He J., Yang Y., and, Peng D. Q., (2012) Monosodium urate (MSU) crystals increase gout associated coronary heart disease (CHD) risk through the activation of NLRP3 inflammasome. Int. J. Cardiol. 160, 72-73. doi: 10.1016/j.ijcard.2012.05.083.
33. Heneka M. T., Kummer M. P., Stutz A., Delekate A., Schwartz S., Vieira-Saecker A., and, Golenbock D. T., (2013) NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678. doi: 10.1038/nature11729.
34. Heneka M. T., Golenbock D. T., and, Latz E., (2015) Innate immunity in Alzheimer's disease. Nat. Immunol. 16, 229-236. doi: 10.1038/ni.3102.
35. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D. R., and, Fitzgerald K. A., (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514-518. doi: 10.1038/nature07725.
36. Inoue M., Williams K. L., Gunn M. D., and, Shinohara M. L., (2012a) NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 109, 10480-10485. doi: 10.1073/pnas.1201836109.
37. Inoue M., Williams K. L., Oliver T., Vandenabeele P., Rajan J. V., Miao E. A., and, Shinohara M. L., (2012b). Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci. Signal. 5, ra38. doi: 10.1126/scisignal.2002767
38. Jha S., Srivastava S. Y., Brickey W. J., Iocca H., Toews A., Morrison J. P., and, Ting J. P., (2010) The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J. Neurosci. 30, 15811-15820. doi: 10.1523/JNEUROSCI.4088-10.2010.
39. Karni A., Koldzic D. N., Bharanidharan P., Khoury S. J., and, Weiner H. L., (2002) IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions. J. Neuroimmunol. 125, 134-140.
40. Krishnaswamy J. K., Singh A., Gowthaman U., Wu R., Gorrepati P., Sales Nascimento M., and, Eisenbarth S. C., (2015) Coincidental loss of DOCK8 function in NLRP10-deficient and C3H/HeJ mice results in defective dendritic cell migration. Proc. Natl Acad. Sci. USA 112, 3056-3061. doi: 10.1073/pnas.1501554112.
41. Kummer J. A., Broekhuizen R., Everett H., Agostini L., Kuijk L., Martinon F., and, Tschopp J., (2007) Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem. 55, 443-452. doi: 10.1369/jhc.6A7101.2006.
42. Lalor S. J., Dungan L. S., Sutton C. E., Basdeo S. A., Fletcher J. M., and, Mills K. H., (2011) Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J. Immunol. 186, 5738-5748. doi: 10.4049/jimmunol.1003597.
43. Liu L., and, Chan C., (2014) IPAF inflammasome is involved in interleukin-1beta production from astrocytes, induced by palmitate; implications for Alzheimer's Disease. Neurobiol. Aging 35, 309-321. doi: 10.1016/j.neurobiolaging.2013.08.016.
44. Liu H. D., Li W., Chen Z. R., Hu Y. C., Zhang D. D., Shen W., and, Hang C. H., (2013) Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem. Res. 38, 2072-2083. doi: 10.1007/s11064-013-1115-z.
45. Losy J., and, Niezgoda A., (2001) IL-18 in patients with multiple sclerosis. Acta Neurol. Scand. 104, 171-173.
46. Lozano D., Gonzales-Portillo G. S., Acosta S., de la Pena I., Tajiri N., Kaneko Y., and, Borlongan C. V., (2015) Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr. Dis. Treat. 11, 97-106. doi: 10.2147/ndt.s65815.
47. Lu A., Magupalli V. G., Ruan J., Yin Q., Atianand M. K., Vos M. R., and, Egelman E. H., (2014) Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156, 1193-1206. doi: 10.1016/j.cell.2014.02.008.
48. Malhotra S., Rio J., Urcelay E., Nurtdinov R., Bustamante M. F., Fernandez O., and, Comabella M., (2015) NLRP3 inflammasome is associated with the response to IFN-beta in patients with multiple sclerosis. Brain. doi: 10.1093/brain/awu388.
49. Mann C. L., Davies M. B., Stevenson V. L., Leary S. M., Boggild M. D., Ko Ko C., and, Hawkins C. P., (2002) Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J. Neuroimmunol. 129, 197-204.
50. Martinon F., (2010) Signaling by ROS drives inflammasome activation. Eur. J. Immunol. 40, 616-619. doi: 10.1002/eji.200940168.
51. Martinon F., Petrilli V., Mayor A., Tardivel A., and, Tschopp J., (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241. doi: 10.1038/nature04516.
52. Mbye L. H., Singh I. N., Sullivan P. G., Springer J. E., and, Hall E. D., (2008) Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a non-immunosuppressive cyclosporin A analog. Exp. Neurol. 209, 243-253. doi: 10.1016/j.expneurol.2007.09.025.
53. McClain C. J., Cohen D., Ott L., Dinarello C. A., and, Young B., (1987) Ventricular fluid interleukin-1 activity in patients with head injury. J. Lab. Clin. Med. 110, 48-54.
54. Meyer-Luehmann M., Spires-Jones T. L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., and, Hyman B. T., (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451, 720-724. doi: 10.1038/nature06616.
55. Miao E. A., Alpuche-Aranda C. M., Dors M., Clark A. E., Bader M. W., Miller S. I., and, Aderem A., (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7, 569-575. doi: 10.1038/ni1344.
56. Munoz-Planillo R., Kuffa P., Martinez-Colon G., Smith B. L., Rajendiran T. M., and, Nunez G., (2013) K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142-1153. doi: 10.1016/j.immuni.2013.05.016.
57. Murphy N., Grehan B., and, Lynch M. A., (2014) Glial uptake of amyloid beta induces NLRP3 inflammasome formation via cathepsin-dependent degradation of NLRP10. Neuromolecular Med. 16, 205-215. doi: 10.1007/s12017-013-8274-6.
58. Ojala J., Alafuzoff I., Herukka S. K., van Groen T., Tanila H., and, Pirttila T., (2009) Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol. Aging 30, 198-209. doi: 10.1016/j.neurobiolaging.2007.06.006.
59. Pontillo A., Catamo E., Arosio B., Mari D., and, Crovella S., (2012) NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 26, 277-281. doi: 10.1097/WAD.0b013e318231a8ac.
60. Riggio S., (2011). Traumatic brain injury and its neurobehavioral sequelae. Neurol. Clin. 29, 35-47, vii. doi: 10.1016/j.ncl.2010.10.008
61. de Rivero Vaccari J. P., Lotocki G., Alonso O. F., Bramlett H. M., Dietrich W. D., and, Keane R. W., (2009) Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J. Cereb. Blood Flow Metab. 29, 1251-1261. doi: 10.1038/jcbfm.2009.46.
62. de Rivero Vaccari J. P., Brand F., 3rd, Adamczak S., Lee S. W., Barcena J. P., Wang M. Y., and, Keane R. W., (2015) Exosome-mediated inflammasome signaling after central nervous system injury. J. Neurochem. doi: 10.1111/jnc.13036.
63. Sato F., Martinez N. E., Omura S., and, Tsunoda I., (2011) Heterogeneity versus homogeneity of multiple sclerosis. Expert Rev. Clin. Immunol. 7, 165-167. doi: 10.1586/eci.11.3.
64. Shaftel S. S., Carlson T. J., Olschowka J. A., Kyrkanides S., Matousek S. B., and, O'Banion M. K., (2007) Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J. Neurosci. 27, 9301-9309. doi: 10.1523/JNEUROSCI.1418-07.2007.
65. Shaw P. J., Lukens J. R., Burns S., Chi H., McGargill M. A., and, Kanneganti T. D., (2010) Cutting edge: critical role for PYCARD/ASC in the development of experimental autoimmune encephalomyelitis. J. Immunol. 184, 4610-4614. doi: 10.4049/jimmunol.1000217.
66. Shaw P. J., McDermott M. F., and, Kanneganti T. D., (2011) Inflammasomes and autoimmunity. Trends Mol. Med. 17, 57-64. doi: 10.1016/j.molmed.2010.11.001.
67. Steinman L., (2008) Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 118, 3557-3563. doi: 10.1172/JCI36532.
68. Tan M. S., Tan L., Jiang T., Zhu X. C., Wang H. F., Jia C. D., and, Yu J. T., (2014) Amyloid-beta induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer's disease. Cell Death Dis. 5, e1382. doi: 10.1038/cddis.2014.348.
69. Vehmas A. K., Kawas C. H., Stewart W. F., and, Troncoso J. C., (2003) Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol. Aging 24, 321-331.
70. Wang Y., Hasegawa M., Imamura R., Kinoshita T., Kondo C., Konaka K., and, Suda T., (2004) PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1. Int. Immunol. 16, 777-786. doi: 10.1093/intimm/dxh081.
71. Weiner H. L., and, Frenkel D., (2006) Immunology and immunotherapy of Alzheimer's disease. Nat. Rev. Immunol. 6, 404-416. doi: 10.1038/nri1843.
72. Yatsiv I., Morganti-Kossmann M. C., Perez D., Dinarello C. A., Novick D., Rubinstein M., and, Stahel P. F., (2002) Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J. Cereb. Blood Flow Metab. 22, 971-978. doi: 10.1097/00004647-200208000-00008.